Receptors, Vascular Endothelial Growth Factor
- Name
- Receptors, Vascular Endothelial Growth Factor
- Accession Number
- DBCAT000830
- Description
A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular IG-LIKE DOMAINS which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.
- Drugs
Drug Drug Description VEGFR2-169 VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)). - Drugs & Drug Targets
Drug Target Type